Cells were cared for for 24h with wild-type rhTFAM or MTS-lacking mutant rhTFAM (MTS-rhTFAM) protein (100nM), prepared while described previously27
Cells were cared for for 24h with wild-type rhTFAM or MTS-lacking mutant rhTFAM (MTS-rhTFAM) protein (100nM), prepared while described previously27. breaks in mtDNA, and impaired neuritogenesis with a reduced expression of transthyretin, which is known to be downregulated by oxidative stress. Extracellular treatment with recombinant hTFAM effectively under control these bad outcomes. Furthermore, the treatment…